Artal Group as of March 31, 2022
Portfolio Holdings for Artal Group
Artal Group holds 136 positions in its portfolio as reported in the March 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Argenx Se Sponsored Adr (ARGX) | 7.8 | $185M | 588k | 315.31 | |
Ww Intl (WW) | 6.3 | $152M | 15M | 10.23 | |
Lexicon Pharmaceuticals Com New (LXRX) | 6.2 | $149M | 71M | 2.09 | |
Beigene Sponsored Adr (BGNE) | 5.3 | $125M | 665k | 188.60 | |
Mirati Therapeutics | 4.6 | $111M | 1.4M | 82.22 | |
Alnylam Pharmaceuticals (ALNY) | 4.4 | $106M | 650k | 163.29 | |
Seagen | 3.9 | $94M | 650k | 144.05 | |
Fate Therapeutics (FATE) | 3.2 | $78M | 2.0M | 38.77 | |
Seer Com Cl A (SEER) | 3.0 | $72M | 4.8M | 15.24 | |
Morphic Hldg (MORF) | 2.8 | $66M | 1.7M | 40.15 | |
Bellus Health Com New | 2.4 | $59M | 8.5M | 6.88 | |
Igm Biosciences (IGMS) | 2.2 | $54M | 2.0M | 26.73 | |
Cerevel Therapeutics Hldng I (CERE) | 2.2 | $53M | 1.5M | 35.01 | |
Springworks Therapeutics (SWTX) | 2.0 | $48M | 850k | 56.44 | |
Kymera Therapeutics (KYMR) | 1.8 | $42M | 1.0M | 42.32 | |
Amicus Therapeutics (FOLD) | 1.6 | $38M | 4.0M | 9.47 | |
Cytokinetics Com New (CYTK) | 1.5 | $37M | 1.0M | 36.81 | |
Krystal Biotech (KRYS) | 1.4 | $33M | 500k | 66.54 | |
Sage Therapeutics (SAGE) | 1.4 | $33M | 1.0M | 33.10 | |
Scholar Rock Hldg Corp (SRRK) | 1.3 | $32M | 2.5M | 12.89 | |
Erasca (ERAS) | 1.1 | $27M | 3.2M | 8.60 | |
Foghorn Therapeutics (FHTX) | 1.1 | $26M | 1.7M | 15.23 | |
Schrodinger (SDGR) | 1.0 | $24M | 700k | 34.12 | |
Relay Therapeutics (RLAY) | 0.9 | $21M | 700k | 29.93 | |
Generation Bio (GBIO) | 0.9 | $21M | 2.8M | 7.34 | |
Gossamer Bio (GOSS) | 0.9 | $21M | 2.4M | 8.68 | |
Rubius Therapeutics | 0.9 | $20M | 3.7M | 5.51 | |
Talaris Therapeutics | 0.9 | $20M | 2.1M | 9.84 | |
Intellia Therapeutics (NTLA) | 0.8 | $20M | 275k | 72.67 | |
Denali Therapeutics (DNLI) | 0.8 | $19M | 600k | 32.17 | |
Protagonist Therapeutics (PTGX) | 0.8 | $19M | 800k | 23.68 | |
Evotec Sponsored Ads (EVO) | 0.7 | $17M | 1.1M | 15.13 | |
Kura Oncology (KURA) | 0.7 | $17M | 1.1M | 16.08 | |
Eqrx | 0.7 | $17M | 4.0M | 4.13 | |
Allovir (ALVR) | 0.7 | $16M | 2.3M | 6.75 | |
Replimune Group (REPL) | 0.6 | $15M | 900k | 16.98 | |
Intel Corporation Call Option (INTC) | 0.6 | $15M | 300k | 49.52 | |
Omega Therapeutics Common Stock (OMGA) | 0.6 | $14M | 2.3M | 6.24 | |
Aptinyx | 0.6 | $14M | 6.1M | 2.27 | |
I Mab Sponsored Ads (IMAB) | 0.6 | $14M | 850k | 16.24 | |
Agenus Com New | 0.6 | $14M | 5.5M | 2.46 | |
Iteos Therapeutics (ITOS) | 0.5 | $13M | 400k | 32.18 | |
Aurinia Pharmaceuticals (AUPH) | 0.5 | $12M | 1.0M | 12.38 | |
Praxis Precision Medicines I | 0.5 | $12M | 1.2M | 10.21 | |
Kronos Bio (KRON) | 0.5 | $11M | 1.5M | 7.23 | |
Apellis Pharmaceuticals (APLS) | 0.4 | $10M | 200k | 50.81 | |
Repare Therapeutics Ord (RPTX) | 0.4 | $10M | 700k | 14.24 | |
Ikena Oncology (IKNA) | 0.4 | $9.5M | 1.5M | 6.10 | |
Marinus Pharmaceuticals Com New (MRNS) | 0.4 | $9.4M | 1.0M | 9.35 | |
Forma Therapeutics Hldgs SHS | 0.4 | $9.3M | 1.0M | 9.30 | |
Atara Biotherapeutics | 0.4 | $9.3M | 1.0M | 9.29 | |
Verve Therapeutics (VERV) | 0.4 | $9.1M | 400k | 22.82 | |
Ambrx Biopharma Sponsored Ads | 0.4 | $8.9M | 2.2M | 4.12 | |
Mersana Therapeutics (MRSN) | 0.4 | $8.8M | 2.2M | 3.99 | |
Alx Oncology Hldgs (ALXO) | 0.4 | $8.5M | 500k | 16.90 | |
Exscientia Ads (EXAI) | 0.3 | $7.9M | 550k | 14.40 | |
Immunic (IMUX) | 0.3 | $7.9M | 700k | 11.30 | |
Vigil Neuroscience (VIGL) | 0.3 | $7.9M | 1.1M | 7.03 | |
Ovid Therapeutics (OVID) | 0.3 | $7.9M | 2.5M | 3.14 | |
Sqz Biotech (SQZB) | 0.3 | $7.7M | 1.6M | 4.81 | |
Tg Therapeutics (TGTX) | 0.3 | $7.6M | 800k | 9.51 | |
Oatly Group Ab Sponsored Ads (OTLY) | 0.3 | $7.5M | 1.5M | 5.01 | |
Nanobiotix Sa Sponsored Ads (NBTX) | 0.3 | $7.4M | 1.0M | 7.44 | |
Omega Alpha Spac Cl A | 0.3 | $7.4M | 750k | 9.82 | |
Leap Therapeutics | 0.3 | $7.0M | 4.0M | 1.75 | |
Sea Sponsored Ads (SE) | 0.3 | $6.9M | 58k | 119.79 | |
Taysha Gene Therapies Com Shs (TSHA) | 0.3 | $6.8M | 1.0M | 6.52 | |
Achilles Therapeutics Sponsored Ads (ACHL) | 0.3 | $6.6M | 2.3M | 2.94 | |
Design Therapeutics (DSGN) | 0.3 | $6.5M | 400k | 16.15 | |
Immunocore Hldgs Ads (IMCR) | 0.3 | $6.0M | 200k | 29.90 | |
Fusion Pharmaceuticals | 0.2 | $5.8M | 750k | 7.77 | |
Contrafect Corp Com New | 0.2 | $5.5M | 1.5M | 3.65 | |
Alpine Immune Sciences | 0.2 | $5.3M | 593k | 8.97 | |
Stoke Therapeutics (STOK) | 0.2 | $5.3M | 250k | 21.05 | |
Dyne Therapeutics (DYN) | 0.2 | $5.1M | 525k | 9.64 | |
Neximmune | 0.2 | $5.1M | 1.2M | 4.21 | |
Harpoon Therapeutics | 0.2 | $5.0M | 1.0M | 4.97 | |
Dynamics Special Purpose Cor Class A Com | 0.2 | $4.9M | 500k | 9.87 | |
Selecta Biosciences | 0.2 | $4.9M | 4.0M | 1.23 | |
Instil Bio | 0.2 | $4.8M | 450k | 10.75 | |
Y Mabs Therapeutics (YMAB) | 0.2 | $4.8M | 400k | 11.88 | |
Avidity Biosciences Ord (RNA) | 0.2 | $4.6M | 250k | 18.47 | |
Black Diamond Therapeutics (BDTX) | 0.2 | $4.6M | 1.6M | 2.77 | |
Adagio Therapeutics (IVVD) | 0.2 | $4.6M | 1.0M | 4.56 | |
Spero Therapeutics (SPRO) | 0.2 | $4.4M | 500k | 8.70 | |
Hookipa Pharma Inc equity | 0.2 | $4.2M | 1.8M | 2.28 | |
Syros Pharmaceuticals | 0.2 | $4.2M | 3.5M | 1.19 | |
Mirion Technologies Com Cl A (MIR) | 0.2 | $4.0M | 500k | 8.07 | |
Ac Immune Sa SHS (ACIU) | 0.2 | $4.0M | 1.0M | 4.00 | |
Adverum Biotechnologies | 0.2 | $3.9M | 3.0M | 1.31 | |
Portage Fintech Acquisitn Class A Ord Shs (PFTA) | 0.2 | $3.8M | 380k | 9.93 | |
Solid Biosciences | 0.2 | $3.6M | 3.0M | 1.20 | |
Graphite Bio | 0.1 | $3.6M | 700k | 5.10 | |
Lyell Immunopharma (LYEL) | 0.1 | $3.5M | 700k | 5.05 | |
Adagene Ads (ADAG) | 0.1 | $3.5M | 1.0M | 3.50 | |
Vor Biopharma (VOR) | 0.1 | $3.3M | 550k | 6.04 | |
Sana Biotechnology (SANA) | 0.1 | $3.3M | 400k | 8.26 | |
Recursion Pharmaceuticals In Cl A (RXRX) | 0.1 | $3.2M | 450k | 7.16 | |
Xilio Therapeutics (XLO) | 0.1 | $3.2M | 450k | 7.07 | |
Curis Com New | 0.1 | $3.1M | 1.3M | 2.38 | |
Gritstone Oncology Ord (GRTS) | 0.1 | $3.1M | 750k | 4.12 | |
Cyclerion Therapeutics | 0.1 | $3.1M | 2.8M | 1.11 | |
Zymeworks | 0.1 | $2.9M | 450k | 6.55 | |
Immutep Sponsored Ads (IMMP) | 0.1 | $2.7M | 1.0M | 2.74 | |
Cullinan Oncology (CGEM) | 0.1 | $2.6M | 250k | 10.47 | |
111 Ads (YI) | 0.1 | $2.6M | 966k | 2.66 | |
Bridgebio Pharma (BBIO) | 0.1 | $2.5M | 250k | 10.15 | |
23andme Holding Class A Com (ME) | 0.1 | $2.5M | 661k | 3.83 | |
Aravive | 0.1 | $2.5M | 1.3M | 1.93 | |
Oric Pharmaceuticals (ORIC) | 0.1 | $2.1M | 400k | 5.34 | |
Tcr2 Therapeutics Inc cs | 0.1 | $2.1M | 750k | 2.76 | |
Wave Life Sciences SHS (WVE) | 0.1 | $2.0M | 1.0M | 2.00 | |
Cardiff Oncology (CRDF) | 0.1 | $1.9M | 750k | 2.48 | |
Axcella Health Inc equity | 0.1 | $1.8M | 713k | 2.57 | |
Mereo Biopharma Group Ads (MREO) | 0.1 | $1.7M | 1.5M | 1.12 | |
Kinnate Biopharma | 0.1 | $1.4M | 125k | 11.26 | |
Ironwood Pharmaceuticals Com Cl A (IRWD) | 0.1 | $1.4M | 111k | 12.58 | |
Orchard Therapeutics Ads | 0.1 | $1.3M | 1.8M | 0.71 | |
Codiak Biosciences | 0.1 | $1.3M | 200k | 6.27 | |
Hippo Hldgs Common Stock | 0.0 | $1.2M | 600k | 1.99 | |
Olema Pharmaceuticals (OLMA) | 0.0 | $1.1M | 261k | 4.26 | |
XP Cl A (XP) | 0.0 | $1.1M | 35k | 30.11 | |
Caribou Biosciences (CRBU) | 0.0 | $967k | 105k | 9.18 | |
Amylyx Pharmaceuticals (AMLX) | 0.0 | $964k | 75k | 12.85 | |
Lava Therapeutics Nv SHS (LVTX) | 0.0 | $880k | 200k | 4.40 | |
Applied Therapeutics (APLT) | 0.0 | $844k | 400k | 2.11 | |
Kaleido Biosciences Ord (KLDO) | 0.0 | $826k | 501k | 1.65 | |
Corvus Pharmaceuticals (CRVS) | 0.0 | $820k | 500k | 1.64 | |
Mink Therapeutics (INKT) | 0.0 | $652k | 290k | 2.25 | |
Mei Pharma Com New | 0.0 | $603k | 1.0M | 0.60 | |
Metacrine Ord | 0.0 | $564k | 925k | 0.61 | |
Sigilon Therapeutics | 0.0 | $406k | 276k | 1.47 | |
Yumanity Therapeutics | 0.0 | $326k | 217k | 1.50 | |
Astria Therapeutics (ATXS) | 0.0 | $224k | 33k | 6.72 | |
Ginkgo Bioworks Holdings Cl A Shs (DNA) | 0.0 | $202k | 50k | 4.04 | |
Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.0 | $187k | 225k | 0.83 |